Indicated for improving luminal diameter in patients with diabetes mellitus, acute myocardial infarction, symptomatic heart disease, stable angina, unstable angina or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with reference vessel diameter 2.25 mm to 5.00 mm and lesions of length ≤ 48 mm
iVascular
Angiolite BTK
Sirolimus
Cobalt chromium (CoCr L605)
Biostable fluorinated acrylate
0.014
5
2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5
9, 14, 16, 19, 24, 29, 34, 39
142
Indicated for treating chronic and acute arterial lesions in the lower limbs below the knee, as well as popliteal and infrapopliteal lesions with reference vessel diameters between 2–4.5 mm, with the aim of increasing the internal diameter of an artery and consequently improving blood flow in the following cases: severe claudication and critical limb ischemia; also indicated for the treatment of erection-related arterial lesions in patients with arteriogenic erectile dysfunction to restore arterial flow to the corpora cavernosa
Indicated for improving infrapopliteal luminal diameter for the treatment of occlusive lesions BTK and above the ankle that lead to severe claudication or CLI; treated infrapopliteal arteries must have a reference diameter ranging between 2.25–4 mm
Polymer-based technology with proven biocompatibility
0.035
6
6–7
40, 60, 80, 100, 120, 150
75, 130
SFA and/or PPA
Concept Medical
Focus NP
Sirolimus
Cobalt chromium alloy L605
Polymer free
0.014
5
2.25, 2.50, 2.75, 3, 3.50, 4
8, 12, 16, 20, 24, 28, 32, 36, 40
140
Indicated for improving luminal diameter in patients, including those with diabetes mellitus, acute myocardial infarction, symptomatic coronary artery disease, stable angina, unstable angina or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with reference vessel diameter 2.25 mm to 4.00 mm and lesions of
length ≤ 36 mm
Zylox-Tonbridge Medical Technology Co., Ltd.
Zenflex Pro Peripheral Drug-Eluting Stent System
Paclitaxel (3 μg/mm²)
Nitinol
None
0.035
6
5, 6, 7
20, 30, 40, 60, 80, 100, 120, 150
80, 125
Indicated for improving luminal diameter in the treatment of de novo or restenotic symptomatic lesion(s) in native vascular disease of the above-the-knee femoropopliteal arteries with reference vessel diameter from 4.0 mm to 6.5 mm
Cook Medical
Zilver PTX
Paclitaxel
Nitinol
Polymer free
0.035
6
5–8
40, 60, 80, 100, 120, 140
80, 125
Above-the-knee femoropopliteal arteries
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!